Next generation first-line NNRTI, rilpivirine (TMC278) potent; lowest dose better-tolerated than efavirenz at 96 weeks
Fri, 05 Dec 2008 11:02:19 GMT
`Express care` by nurses for people starting HIV treatment decreases clinic congestion, and may improve outcomes
Fri, 05 Dec 2008 11:02:19 GMT
Heat-stable ritonavir tablet equivalent to soft gel capsule; may be approved next year
Fri, 05 Dec 2008 11:02:19 GMT
Erection loss with condoms predicts subsequent unsafe sex
Fri, 05 Dec 2008 11:02:19 GMT
Uptake of second-line treatment `stagnant` in developing world
Fri, 05 Dec 2008 11:02:19 GMT
Ethnic minority gay men in UK have very different rates of HIV infection despite similar behaviours
Fri, 05 Dec 2008 11:02:19 GMT
Three per cent of TB cases in Lisbon found to be extensively drug-resistant
Fri, 05 Dec 2008 11:02:19 GMT
One in five patients at London clinic are lost to follow-up and do not attend elsewhere in the UK
Fri, 05 Dec 2008 11:02:19 GMT
Hepatitis C coinfection may increase the risk of heart attacks and strokes in people with HIV
Fri, 05 Dec 2008 11:02:19 GMT
Occult hepatitis B is more common in people with HIV, but occult hepatitis C is rare
Fri, 05 Dec 2008 11:02:19 GMT
Monkey study strengthens the case for a microbicide combining several anti-HIV drugs
Fri, 05 Dec 2008 11:02:19 GMT
Systematic review unable to confirm or deny Swiss statement on infection risk with undetectable viral load
Fri, 05 Dec 2008 11:02:19 GMT
Two new NNRTIs look promising in early clinical trials
Fri, 05 Dec 2008 11:02:19 GMT
Which gay men should be the target for prevention work?
Fri, 05 Dec 2008 11:02:19 GMT
High prevalence of hepatitis C in Dutch HIV-positive gay men
Fri, 05 Dec 2008 11:02:19 GMT
Protective effect of circumcision is sustained for at least 3.5 years; also works against HPV
Fri, 05 Dec 2008 11:02:19 GMT
Men more likely to drop out of clinic care than women in western Kenya
Fri, 05 Dec 2008 11:02:19 GMT
How does abacavir/3TC compare to tenofovir/FTC? ACTG5202 and GSK studies disagree
Fri, 05 Dec 2008 11:02:19 GMT
Two novel immune therapies in early investigation: autologous dendritic cells and CD4 zeta gene-modified T cells
Fri, 05 Dec 2008 11:02:19 GMT
Treatment as prevention tool: enough evidence to say it works, says IAS president
Fri, 05 Dec 2008 11:02:19 GMT
Tenofovir kidney toxicity most likely with high blood pressure medications and PIs
Fri, 05 Dec 2008 11:02:19 GMT
Skills-building behavioural interventions advocated for reducing alcohol-related HIV risk in South Africa
Fri, 05 Dec 2008 11:02:19 GMT
Criminal HIV transmission and exposure laws spreading around the world ‘like a virus’
Fri, 05 Dec 2008 11:02:19 GMT
Prevention – there will be no magic bullet, we need ‘combination prevention’
Fri, 05 Dec 2008 11:02:19 GMT
AIDS in 2031: where will we be?
Fri, 05 Dec 2008 11:02:19 GMT
Major prevention success for sex workers and men who have sex with men in India
Fri, 05 Dec 2008 11:02:19 GMT
Raltegravir versus efavirenz in treatment-naïves at 96 weeks: continued efficacy and fewer adverse effects
Fri, 05 Dec 2008 11:02:19 GMT
Treatment outcomes in Latin America, China and Botswana: successes and shortfalls
Fri, 05 Dec 2008 11:02:19 GMT
Efavirenz superior to lopinavir/ritonavir in very advanced HIV, Mexican trial shows
Fri, 05 Dec 2008 11:02:19 GMT
Infants starting HIV treatment less likely to completely suppress viral load
Fri, 05 Dec 2008 11:02:19 GMT
Slowing CD4 cell decline with IL-2 allows HIV treatment to be deferred by 92 weeks
Fri, 05 Dec 2008 11:02:19 GMT
Circumcision will halve HIV rates but may take decades to reach full impact
Fri, 05 Dec 2008 11:02:19 GMT
Widespread NRTI and NNRTI resistance seen in Malawian patients failing first-line antiretroviral therapy
Fri, 05 Dec 2008 11:02:19 GMT
High HIV incidence among young Thai men who have sex with men
Fri, 05 Dec 2008 11:02:19 GMT
HIV programme in Western Kenya successfully delivers isoniazid preventive therapy to thousands
Fri, 05 Dec 2008 11:02:19 GMT
Swiss statement that ‘undetectable equals uninfectious’ creates more controversy in Mexico City
Fri, 05 Dec 2008 11:02:19 GMT
Who defines ‘Positive prevention’?
Fri, 05 Dec 2008 11:02:19 GMT
South African men with genital ulcers have very high incidence of HIV and should be a target of prevention interventions
Fri, 05 Dec 2008 11:02:19 GMT
HIV-1 subtype, genital ulcer disease influence risk of HIV transmission among heterosexual couples
Fri, 05 Dec 2008 11:02:19 GMT
Earlier ART benefits HIV/TB co-infected patients in Iran; Argentinian study yields uncertain results
Fri, 05 Dec 2008 11:02:19 GMT
Microfinance project reduces HIV risk in South African women, gold standard trial shows
Fri, 05 Dec 2008 11:02:19 GMT
Lipodystrophy common, but does not affect adherence in Thai patients
Fri, 05 Dec 2008 11:02:19 GMT
Invisible men: action urged for gay men in the global South
Fri, 05 Dec 2008 11:02:19 GMT
Switch to atazanavir does not reduce belly fat
Fri, 05 Dec 2008 11:02:19 GMT
US HIV incidence 40% higher than previous estimates, new test shows
Fri, 05 Dec 2008 11:02:19 GMT
Malawi MSM survey reveals very high HIV acquisition and transmission risks
Fri, 05 Dec 2008 11:02:19 GMT
World AIDS conference comes to Latin America
Fri, 05 Dec 2008 11:02:19 GMT